Kestra Investment Management LLC Makes New $380,000 Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Kestra Investment Management LLC purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 773 shares of the medical equipment provider’s stock, valued at approximately $380,000.

A number of other institutional investors also recently modified their holdings of the business. FMR LLC raised its stake in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after acquiring an additional 838,793 shares in the last quarter. Fisher Asset Management LLC grew its holdings in shares of Intuitive Surgical by 1.8% during the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after purchasing an additional 86,208 shares during the last quarter. Baillie Gifford & Co. increased its position in Intuitive Surgical by 0.6% during the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock worth $1,890,676,000 after purchasing an additional 24,183 shares in the last quarter. American Century Companies Inc. lifted its stake in Intuitive Surgical by 3.0% in the 2nd quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider’s stock valued at $1,066,837,000 after purchasing an additional 70,556 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in Intuitive Surgical by 1.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 2,227,467 shares of the medical equipment provider’s stock valued at $1,094,288,000 after buying an additional 28,703 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Mark Brosius sold 2,115 shares of the stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $491.91, for a total value of $1,040,389.65. Following the completion of the transaction, the insider now owns 295 shares in the company, valued at approximately $145,113.45. This represents a 87.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 51,023 shares of company stock worth $26,384,247. Corporate insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the stock. Citigroup upped their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research report on Friday, October 18th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a report on Friday, October 18th. Finally, Raymond James lifted their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $536.61.

Intuitive Surgical Trading Up 0.2 %

Shares of ISRG opened at $542.85 on Tuesday. The firm’s fifty day simple moving average is $510.03 and its two-hundred day simple moving average is $469.49. Intuitive Surgical, Inc. has a 12 month low of $304.50 and a 12 month high of $552.00. The stock has a market capitalization of $193.35 billion, a P/E ratio of 87.27, a price-to-earnings-growth ratio of 5.33 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, research analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.